CIK 0001819133
- Non-accelerated filer
- Smaller reporting company
Tango Therapeutics, Inc.
Sign in to watch- Ticker
- TNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-320-4900
- Business address
- 201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
- Former names
- BCTG Acquisition Corp.
- 4 Open-market sale General Counsel sold 2,776 shares at an average $12.59 ($34,951)
- 4 Open-market sale Chief Financial Officer sold 3,725 shares at an average $12.59 ($46,900)
- 4 Open-market sale Crystal Adam sold 8,371 shares at an average $12.59 ($105,395)
- 4 Grant or award Chief Financial Officer acquired 39,413 shares (grant or award)
- 4 Grant or award Crystal Adam acquired 46,599 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 87,168 shares (grant or award)
- 4 Grant or award General Counsel acquired 22,859 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Crystal Adam sold 7,507 shares at $8.39 ($62,994)
- 4/A Open-market buy Boxer Capital, LLC bought 1,250,000 shares at an average $6.98 ($8,722,500)
- 4 Open-market buy Boxer Capital, LLC bought 1,250,000 shares at an average $6.98 ($8,722,500)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Boxer Capital, LLC sold 225,000 shares at an average $9.96 ($2,240,250)
- 4/A Grant or award Director acquired 475,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Boxer Capital, LLC bought 475,000 shares at $5.15 ($2,446,250)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
Page 5 of 8 · 156 filings